|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 361.50 USD | +0.88% |
|
+4.55% | +10.11% |
| 06-26 | US FDA greenlights Viridian's thyroid eye disease drug | RE |
| 06-26 | US FDA greenlights Viridian's eye disease drug | RE |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 193B | |||||
| 1,077B | |||||
| 613B | |||||
| 448B | |||||
| 332B | |||||
| 293B |
- Stock Market
- Stocks
- AMGN Stock
- Charts Amgen Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
